Invesco Nasdaq Biotechnology ETF (NASDAQ:IBBQ – Get Free Report) was the target of a large decrease in short interest during the month of November. As of November 15th, there was short interest totalling 1,000 shares, a decrease of 93.1% from the October 31st total of 14,500 shares. Based on an average trading volume of 19,100 shares, the days-to-cover ratio is presently 0.1 days.
Invesco Nasdaq Biotechnology ETF Price Performance
NASDAQ IBBQ traded up $0.19 during trading on Wednesday, reaching $23.20. The company’s stock had a trading volume of 6,243 shares, compared to its average volume of 19,243. The stock has a market capitalization of $37.82 million, a PE ratio of 17.39 and a beta of 0.61. The firm has a fifty day moving average of $23.52 and a 200 day moving average of $23.38. Invesco Nasdaq Biotechnology ETF has a one year low of $18.85 and a one year high of $24.84.
Invesco Nasdaq Biotechnology ETF Increases Dividend
The company also recently disclosed a quarterly dividend, which was paid on Friday, September 27th. Stockholders of record on Monday, September 23rd were given a dividend of $0.089 per share. The ex-dividend date of this dividend was Monday, September 23rd. This is a positive change from Invesco Nasdaq Biotechnology ETF’s previous quarterly dividend of $0.05. This represents a $0.36 annualized dividend and a dividend yield of 1.53%.
Hedge Funds Weigh In On Invesco Nasdaq Biotechnology ETF
About Invesco Nasdaq Biotechnology ETF
The Invesco Nasdaq Biotechnology ETF (IBBQ) is an exchange-traded fund that is based on the NASDAQ / Biotechnology index, a modified market-cap-weighted index of US biotechnology and pharmaceutical companies listed on the NASDAQ. IBBQ was launched on Jun 11, 2021 and is managed by Invesco.
Featured Articles
- Five stocks we like better than Invesco Nasdaq Biotechnology ETF
- How to Calculate Options Profits
- Microsoft Stock Gets a $550 Price Target: Time to Get Excited
- The Risks of Owning Bonds
- Trump Tariffs in Focus: 2 Chinese Stocks to Own and 2 to Avoid
- How to Invest in the FAANG Stocks
- 2 Generic Drug Stocks Ready to Surge in 2025
Receive News & Ratings for Invesco Nasdaq Biotechnology ETF Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Invesco Nasdaq Biotechnology ETF and related companies with MarketBeat.com's FREE daily email newsletter.